PRJNA516884
Circulating Tumor DNA Dynamics using Patient-Customized Assays are Associated with Outcome in Neoadjuvantly-Treated Breast Cancer
Using variants identified in primary and metastatic tumors by whole-exome sequencing, circulating tumor DNA found in cell-free DNA can be analysed for signs of residual disease or treatment response.